These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 8934562

  • 1. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid.
    Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ.
    Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562
    [Abstract] [Full Text] [Related]

  • 2. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM, Volicer L, Hauser SL, Wands JR.
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [Abstract] [Full Text] [Related]

  • 3. Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.
    Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I.
    J Alzheimers Dis; 2009 Dec; 17(4):863-73. PubMed ID: 19542614
    [Abstract] [Full Text] [Related]

  • 4. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
    Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P.
    Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
    [Abstract] [Full Text] [Related]

  • 5. Concentrations of amyloid beta protein in cerebrospinal fluid of patients with Alzheimer's disease.
    van Gool WA, Kuiper MA, Walstra GJ, Wolters EC, Bolhuis PA.
    Ann Neurol; 1995 Feb; 37(2):277-9. PubMed ID: 7847870
    [Abstract] [Full Text] [Related]

  • 6. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury.
    Ost M, Nylén K, Csajbok L, Ohrfelt AO, Tullberg M, Wikkelsö C, Nellgård P, Rosengren L, Blennow K, Nellgård B.
    Neurology; 2006 Nov 14; 67(9):1600-4. PubMed ID: 17101890
    [Abstract] [Full Text] [Related]

  • 7. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C, Murata T, Sato C, Terayama Y.
    Life Sci; 2005 Aug 26; 77(15):1836-43. PubMed ID: 15935398
    [Abstract] [Full Text] [Related]

  • 8. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC, Kardamakis D, Ravazoula P, Zolota V, Salakou S, Tepetes K, Kalogeropoulou C, Tsota I, Kourelis T, Makatsoris T, Karavias D, Scopa CD, Bonikos DS, Kalofonos HP, Petsas T.
    Strahlenther Onkol; 2004 Apr 26; 180(4):201-8. PubMed ID: 15057430
    [Abstract] [Full Text] [Related]

  • 9. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.
    Zetterberg H, Andreasen N, Blennow K.
    Neurosci Lett; 2004 Sep 02; 367(2):194-6. PubMed ID: 15331151
    [Abstract] [Full Text] [Related]

  • 10. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score.
    Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP.
    Rheumatology (Oxford); 2005 Dec 02; 44(12):1518-24. PubMed ID: 16159952
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L, Tiraboschi P, Lanari A, Peducci M, Padiglioni C, D'Amore C, Pierguidi L, Tambasco N, Rossi A, Calabresi P.
    Biol Psychiatry; 2008 Nov 15; 64(10):850-5. PubMed ID: 18395699
    [Abstract] [Full Text] [Related]

  • 12. TGFbeta1 and TGFbeta2 mRNA and protein expression in human bone samples.
    Hering S, Isken E, Knabbe C, Janott J, Jost C, Pommer A, Muhr G, Schatz H, Pfeiffer AF.
    Exp Clin Endocrinol Diabetes; 2001 Nov 15; 109(4):217-26. PubMed ID: 11453034
    [Abstract] [Full Text] [Related]

  • 13. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Rentzos M, Zoga M, Paraskevas GP, Kapaki E, Rombos A, Nikolaou C, Tsoutsou A, Vassilopoulos D.
    J Geriatr Psychiatry Neurol; 2006 Jun 15; 19(2):114-7. PubMed ID: 16690997
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture.
    Yu SJ, Lo ES, Cochran EJ, Lin DH, Faselis CJ, Klawans HL, Carvey PM.
    Exp Neurol; 1994 Mar 15; 126(1):15-24. PubMed ID: 7908885
    [Abstract] [Full Text] [Related]

  • 15. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
    Sinha A, Srivastava N, Singh S, Singh AK, Bhushan S, Shukla R, Singh MP.
    Clin Chim Acta; 2009 Feb 15; 400(1-2):14-20. PubMed ID: 18977210
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, Blennow K, Zetterberg H.
    Neurosci Lett; 2009 Feb 06; 450(3):332-5. PubMed ID: 19022350
    [Abstract] [Full Text] [Related]

  • 17. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J, Stojsavljević N, Dujmović I, Sokić D, Mavra M, Lević Z.
    Srp Arh Celok Lek; 1995 Feb 06; 123(7-8):191-3. PubMed ID: 17974427
    [Abstract] [Full Text] [Related]

  • 18. Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson's disease.
    Salehi Z, Mashayekhi F.
    J Clin Neurosci; 2009 Jan 06; 16(1):90-3. PubMed ID: 19017558
    [Abstract] [Full Text] [Related]

  • 19. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
    Vagenas K, Spyropoulos C, Gavala V, Tsamandas AC.
    J Surg Res; 2007 May 15; 139(2):182-8. PubMed ID: 17270215
    [Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.
    Kankaanpää J, Turunen SP, Moilanen V, Hörkkö S, Remes AM.
    Neurobiol Dis; 2009 Mar 15; 33(3):467-72. PubMed ID: 19130885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.